Cleared Traditional

K192221 - Legacy2

Also marketed or referenced as:
Legacy2, Legacy3, Legacy4 fixture-mounts

K192221 is an FDA 510(k) clearance for Legacy2, manufactured by Implant Direct Sybron Manufacturing, LLC. The device is a Class 2 Dental device with product code DZE cleared through the Traditional 510(k) pathway after a 315-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2020
Decision
315d
Days
Class 2
Risk

K192221 is an FDA 510(k) clearance for the Legacy2, Legacy3, Legacy4, simplyLegacy2, simplyLegacy3 dental implants. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Implant Direct Sybron Manufacturing, LLC (Thousand Oaks, US). The FDA issued a Cleared decision on June 25, 2020 after a review of 315 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Implant Direct Sybron Manufacturing, LLC devices

FDA 510(k) Submission Details - K192221

510(k) Number K192221 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2019
Decision Date June 25, 2020
Days to Decision 315 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
188d slower than avg
Panel avg: 127d · This submission: 315d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Consultant

Hogan & Lovells U.S. Lpp
Kelliann Payne

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 758
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K192221.
I Do
K192294 · I DO Biotech Co., Ltd. · Jul 2020
JDentalCare Implant System JDIcon
K182081 · Jdentalcare Srl · Jun 2020
MSDI Dental Implants System
K191443 · Medical Systems and Devices International , Ltd. · Jun 2020
Fit & Brilliant Dental Implant System
K190637 · F&B Technology Co., Ltd. · Jun 2020
BV Dental Implant System
K192274 · Bio Concept Co., Ltd. · Jun 2020
NUVO IF Implant System
K193234 · Jjgc Industria E Comercio DE Materiais Dentarios S.A. · Jun 2020